We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The move is aimed at facilitating the availability of new drugs which are in Phase-III clinical trials (human trials) for severely-ill COVID-19 patients in the country.